MDA-MDMA concentrations in urine specimens

Area of Science:

• Forensic Toxicology
• Analytical Chemistry
• Pharmacology

Background:

• Routine drug testing in active-duty military personnel is crucial for maintaining force readiness.
• Initial screening tests for amphetamines can sometimes yield ambiguous results requiring further confirmation.
• Distinguishing between different amphetamine-class substances is important for accurate identification and interpretation.

Purpose of the Study:

• To confirm the identity of amphetamine-like substances detected in U.S. Army personnel urine samples.
• To quantify the levels of identified substances and their metabolites.
• To determine if the detected drug profile is consistent with the use of 3,4-methylenedioxymethamphetamine (MDMA) only.

Main Methods:

• Urine specimens were initially screened for amphetamines using radioimmunoassay and immunoassay methods.
• Suspected samples were further analyzed using gas chromatographic-mass spectrometric (GC-MS) analysis for confirmation and quantitation.
• Concentrations of MDMA and its metabolite MDA were measured, and their ratios were calculated.

Main Results:

• Thirty-four urine specimens initially screened positive for amphetamines were confirmed to contain both MDMA and MDA.
• MDMA concentrations ranged from 0.38 to 96.2 mg/L (mean 13.4 mg/L), and MDA concentrations ranged from 0.15 to 8.6 mg/L (mean 1.6 mg/L).
• The mean ratio of MDA to MDMA was 0.15, consistent with the known metabolic pathway of MDMA.

Conclusions:

• The co-detection of MDMA and its metabolite MDA in military urine samples strongly indicates MDMA use.
• The observed MDA to MDMA concentration ratio supports MDMA as the sole substance used, differentiating it from combined use with other amphetamines.
• GC-MS analysis is essential for accurate identification and differentiation of controlled substances in forensic toxicology.